1	Institut	_	NNP	_	_	2	NAME	_	_
2	Merieux	_	NNP	_	_	6	SBJ	_	_
3	S.A.	_	NNP	_	_	2	POSTHON	_	_
4	of	_	IN	_	_	2	NMOD	_	_
5	France	_	NNP	_	_	4	PMOD	_	_
6	said	_	VBD	_	_	0	ROOT	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	Canadian	_	JJ	_	_	9	NMOD	_	_
9	government	_	NN	_	_	10	SBJ	_	_
10	raised	_	VBD	_	_	6	OBJ	_	_
11	an	_	DT	_	_	12	NMOD	_	_
12	obstacle	_	NN	_	_	10	OBJ	_	_
13	to	_	TO	_	_	12	NMOD	_	_
14	its	_	PRP$	_	_	16	NMOD	_	_
15	proposed	_	JJ	_	_	16	NMOD	_	_
16	acquisition	_	NN	_	_	13	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	Connaught	_	NNP	_	_	19	NAME	_	_
19	BioSciences	_	NNP	_	_	17	PMOD	_	_
20	Inc.	_	NNP	_	_	19	POSTHON	_	_
21	for	_	IN	_	_	16	NMOD	_	_
22	942	_	CD	_	_	23	DEP	_	_
23	million	_	CD	_	_	25	NMOD	_	_
24	Canadian	_	JJ	_	_	25	NMOD	_	_
25	dollars	_	NNS	_	_	21	PMOD	_	_
26	(	_	(	_	_	27	P	_	_
27	US$	_	$	_	_	25	PRN	_	_
28	801.6	_	CD	_	_	27	DEP	_	_
29	million	_	CD	_	_	27	DEP	_	_
30	)	_	)	_	_	27	P	_	_
31	.	_	.	_	_	6	P	_	_

1	Merieux	_	NNP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	government	_	NN	_	_	6	NMOD	_	_
5	's	_	POS	_	_	4	SUFFIX	_	_
6	minister	_	NN	_	_	13	SBJ	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	industry	_	NN	_	_	7	PMOD	_	_
9	,	_	,	_	_	8	P	_	_
10	science	_	NN	_	_	8	COORD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	technology	_	NN	_	_	11	CONJ	_	_
13	told	_	VBD	_	_	2	OBJ	_	_
14	it	_	PRP	_	_	13	OBJ	_	_
15	that	_	IN	_	_	13	OBJ	_	_
16	he	_	PRP	_	_	17	SBJ	_	_
17	was	_	VBD	_	_	15	SUB	_	_
18	n't	_	RB	_	_	17	ADV	_	_
19	convinced	_	JJ	_	_	17	PRD	_	_
20	that	_	IN	_	_	19	AMOD	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	purchase	_	NN	_	_	23	SBJ	_	_
23	is	_	VBZ	_	_	20	SUB	_	_
24	likely	_	JJ	_	_	23	PRD	_	_
25	to	_	TO	_	_	24	AMOD	_	_
26	be	_	VB	_	_	25	IM	_	_
27	of	_	IN	_	_	26	PRD	_	_
28	``	_	``	_	_	27	P	_	_
29	net	_	JJ	_	_	30	NMOD	_	_
30	benefit	_	NN	_	_	27	PMOD	_	_
31	''	_	''	_	_	27	P	_	_
32	to	_	TO	_	_	26	ADV	_	_
33	Canada	_	NNP	_	_	32	PMOD	_	_
34	.	_	.	_	_	2	P	_	_

1	Canadian	_	JJ	_	_	3	NMOD	_	_
2	investment	_	NN	_	_	3	NMOD	_	_
3	rules	_	NNS	_	_	4	SBJ	_	_
4	require	_	VBP	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	OBJ	_	_
6	big	_	JJ	_	_	8	NMOD	_	_
7	foreign	_	JJ	_	_	8	NMOD	_	_
8	takeovers	_	NNS	_	_	9	SBJ	_	_
9	meet	_	VB	_	_	5	SUB	_	_
10	that	_	DT	_	_	11	NMOD	_	_
11	standard	_	NN	_	_	9	OBJ	_	_
12	.	_	.	_	_	4	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	French	_	JJ	_	_	3	NMOD	_	_
3	company	_	NN	_	_	4	SBJ	_	_
4	said	_	VBD	_	_	0	ROOT	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	government	_	NN	_	_	7	SBJ	_	_
7	gave	_	VBD	_	_	4	OBJ	_	_
8	it	_	PRP	_	_	7	OBJ	_	_
9	30	_	CD	_	_	10	NMOD	_	_
10	days	_	NNS	_	_	7	OBJ	_	_
11	in	_	IN	_	_	14	TMP	_	_
12	which	_	WDT	_	_	11	PMOD	_	_
13	to	_	TO	_	_	10	NMOD	_	_
14	submit	_	VB	_	_	13	IM	_	_
15	information	_	NN	_	_	14	OBJ	_	_
16	to	_	TO	_	_	15	NMOD	_	_
17	further	_	RB	_	_	16	ADV	_	_
18	support	_	VB	_	_	16	IM	_	_
19	its	_	PRP$	_	_	21	NMOD	_	_
20	takeover	_	NN	_	_	21	NMOD	_	_
21	plan	_	NN	_	_	18	OBJ	_	_
22	.	_	.	_	_	4	P	_	_

1	Both	_	DT	_	_	2	NMOD	_	_
2	Merieux	_	NNP	_	_	5	SBJ	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	Connaught	_	NNP	_	_	3	CONJ	_	_
5	are	_	VBP	_	_	0	ROOT	_	_
6	biotechnology	_	NN	_	_	7	NMOD	_	_
7	research	_	NN	_	_	5	PRD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	vaccine	_	NN	_	_	11	NMOD	_	_
10	manufacturing	_	NN	_	_	11	NMOD	_	_
11	concerns	_	NNS	_	_	8	CONJ	_	_
12	.	_	.	_	_	5	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	government	_	NN	_	_	4	NMOD	_	_
3	's	_	POS	_	_	2	SUFFIX	_	_
4	action	_	NN	_	_	5	SBJ	_	_
5	was	_	VBD	_	_	0	ROOT	_	_
6	unusual	_	JJ	_	_	5	PRD	_	_
7	.	_	.	_	_	5	P	_	_

1	Alan	_	NNP	_	_	2	NAME	_	_
2	Nymark	_	NNP	_	_	16	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	executive	_	JJ	_	_	6	NMOD	_	_
5	vice	_	NN	_	_	6	NMOD	_	_
6	president	_	NN	_	_	2	APPO	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	Investment	_	NNP	_	_	9	NAME	_	_
9	Canada	_	NNP	_	_	7	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	which	_	WDT	_	_	12	SBJ	_	_
12	oversees	_	VBZ	_	_	9	NMOD	_	_
13	foreign	_	JJ	_	_	14	NMOD	_	_
14	takeovers	_	NNS	_	_	12	OBJ	_	_
15	,	_	,	_	_	9	P	_	_
16	said	_	VBD	_	_	0	ROOT	_	_
17	it	_	PRP	_	_	18	SBJ	_	_
18	marked	_	VBD	_	_	16	OBJ	_	_
19	the	_	DT	_	_	21	NMOD	_	_
20	first	_	JJ	_	_	21	NMOD	_	_
21	time	_	NN	_	_	18	OBJ	_	_
22	in	_	IN	_	_	21	LOC	_	_
23	its	_	PRP$	_	_	25	NMOD	_	_
24	four-year	_	JJ	_	_	25	NMOD	_	_
25	history	_	NN	_	_	22	PMOD	_	_
26	that	_	IN	_	_	30	TMP	_	_
27	the	_	DT	_	_	28	NMOD	_	_
28	agency	_	NN	_	_	29	SBJ	_	_
29	has	_	VBZ	_	_	21	NMOD	_	_
30	made	_	VBN	_	_	29	VC	_	_
31	an	_	DT	_	_	34	NMOD	_	_
32	adverse	_	JJ	_	_	34	NMOD	_	_
33	net-benefit	_	JJ	_	_	34	NMOD	_	_
34	decision	_	NN	_	_	30	OBJ	_	_
35	about	_	IN	_	_	34	NMOD	_	_
36	the	_	DT	_	_	37	NMOD	_	_
37	acquisition	_	NN	_	_	35	PMOD	_	_
38	of	_	IN	_	_	37	NMOD	_	_
39	a	_	DT	_	_	42	NMOD	_	_
40	publicly	_	RB	_	_	41	AMOD	_	_
41	traded	_	VBN	_	_	42	NMOD	_	_
42	company	_	NN	_	_	38	PMOD	_	_
43	.	_	.	_	_	16	P	_	_

1	He	_	PRP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	it	_	PRP	_	_	4	SBJ	_	_
4	has	_	VBZ	_	_	2	OBJ	_	_
5	reached	_	VBN	_	_	4	VC	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	same	_	JJ	_	_	8	NMOD	_	_
8	conclusions	_	NNS	_	_	5	OBJ	_	_
9	about	_	IN	_	_	8	NMOD	_	_
10	some	_	DT	_	_	11	NMOD	_	_
11	attempts	_	NNS	_	_	9	PMOD	_	_
12	to	_	TO	_	_	11	NMOD	_	_
13	buy	_	VB	_	_	12	IM	_	_
14	closely	_	RB	_	_	15	AMOD	_	_
15	held	_	VBN	_	_	13	DEP	_	_
16	concerns	_	NNS	_	_	13	DEP	_	_
17	,	_	,	_	_	5	P	_	_
18	but	_	CC	_	_	5	COORD	_	_
19	eventually	_	RB	_	_	20	TMP	_	_
20	allowed	_	VBD	_	_	18	CONJ	_	_
21	those	_	DT	_	_	22	NMOD	_	_
22	acquisitions	_	NNS	_	_	20	OBJ	_	_
23	to	_	TO	_	_	20	OPRD	_	_
24	proceed	_	VB	_	_	23	IM	_	_
25	.	_	.	_	_	2	P	_	_

1	``	_	``	_	_	19	P	_	_
2	This	_	DT	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	19	OBJ	_	_
4	n't	_	RB	_	_	3	ADV	_	_
5	a	_	DT	_	_	6	NMOD	_	_
6	change	_	NN	_	_	3	PRD	_	_
7	in	_	IN	_	_	6	LOC	_	_
8	government	_	NN	_	_	9	NMOD	_	_
9	policy	_	NN	_	_	7	PMOD	_	_
10	;	_	:	_	_	3	P	_	_
11	this	_	DT	_	_	12	NMOD	_	_
12	provision	_	NN	_	_	13	SBJ	_	_
13	has	_	VBZ	_	_	3	COORD	_	_
14	been	_	VBN	_	_	13	VC	_	_
15	used	_	VBN	_	_	14	VC	_	_
16	before	_	RB	_	_	15	TMP	_	_
17	,	_	,	_	_	19	P	_	_
18	''	_	''	_	_	19	P	_	_
19	said	_	VBD	_	_	0	ROOT	_	_
20	Jodi	_	NNP	_	_	21	NAME	_	_
21	Redmond	_	NNP	_	_	19	SBJ	_	_
22	,	_	,	_	_	21	P	_	_
23	press	_	NN	_	_	24	NMOD	_	_
24	secretary	_	NN	_	_	21	APPO	_	_
25	for	_	IN	_	_	24	NMOD	_	_
26	Harvie	_	NNP	_	_	27	NAME	_	_
27	Andre	_	NNP	_	_	25	PMOD	_	_
28	,	_	,	_	_	27	P	_	_
29	Canada	_	NNP	_	_	31	NMOD	_	_
30	's	_	POS	_	_	29	SUFFIX	_	_
31	minister	_	NN	_	_	27	APPO	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	industry	_	NN	_	_	32	PMOD	_	_
34	,	_	,	_	_	33	P	_	_
35	science	_	NN	_	_	33	COORD	_	_
36	and	_	CC	_	_	35	COORD	_	_
37	technology	_	NN	_	_	36	CONJ	_	_
38	.	_	.	_	_	19	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Andre	_	NNP	_	_	3	SBJ	_	_
3	issued	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	ruling	_	NN	_	_	3	OBJ	_	_
6	based	_	VBN	_	_	3	ADV	_	_
7	on	_	IN	_	_	6	PMOD	_	_
8	a	_	DT	_	_	9	NMOD	_	_
9	recommendation	_	NN	_	_	7	PMOD	_	_
10	by	_	IN	_	_	9	NMOD	_	_
11	Investment	_	NNP	_	_	12	NAME	_	_
12	Canada	_	NNP	_	_	10	PMOD	_	_
13	.	_	.	_	_	3	P	_	_

1	Spokesmen	_	NNP	_	_	6	SBJ	_	_
2	for	_	IN	_	_	1	NMOD	_	_
3	Merieux	_	NNP	_	_	2	PMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	Connaught	_	NNP	_	_	4	CONJ	_	_
6	said	_	VBD	_	_	0	ROOT	_	_
7	they	_	PRP	_	_	8	SBJ	_	_
8	had	_	VBD	_	_	6	OBJ	_	_
9	n't	_	RB	_	_	8	ADV	_	_
10	been	_	VBN	_	_	8	VC	_	_
11	informed	_	VBN	_	_	10	VC	_	_
12	of	_	IN	_	_	11	ADV	_	_
13	specific	_	JJ	_	_	14	NMOD	_	_
14	areas	_	NNS	_	_	12	PMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	concern	_	NN	_	_	15	PMOD	_	_
17	by	_	IN	_	_	11	LGS	_	_
18	either	_	CC	_	_	20	DEP	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	government	_	NN	_	_	17	PMOD	_	_
21	or	_	CC	_	_	20	COORD	_	_
22	Investment	_	NNP	_	_	23	NAME	_	_
23	Canada	_	NNP	_	_	21	CONJ	_	_
24	,	_	,	_	_	6	P	_	_
25	but	_	CC	_	_	6	COORD	_	_
26	added	_	VBD	_	_	25	CONJ	_	_
27	they	_	PRP	_	_	28	SBJ	_	_
28	hope	_	VBP	_	_	26	OBJ	_	_
29	to	_	TO	_	_	28	OPRD	_	_
30	have	_	VB	_	_	29	IM	_	_
31	more	_	JJR	_	_	32	NMOD	_	_
32	information	_	NN	_	_	30	OBJ	_	_
33	early	_	RB	_	_	35	NMOD	_	_
34	this	_	DT	_	_	35	NMOD	_	_
35	week	_	NN	_	_	30	TMP	_	_
36	.	_	.	_	_	6	P	_	_

1	Investment	_	NNP	_	_	2	NAME	_	_
2	Canada	_	NNP	_	_	3	SBJ	_	_
3	declined	_	VBD	_	_	0	ROOT	_	_
4	to	_	TO	_	_	3	OPRD	_	_
5	comment	_	VB	_	_	4	IM	_	_
6	on	_	IN	_	_	5	ADV	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	reasons	_	NNS	_	_	6	PMOD	_	_
9	for	_	IN	_	_	8	NMOD	_	_
10	the	_	DT	_	_	12	NMOD	_	_
11	government	_	NN	_	_	12	NMOD	_	_
12	decision	_	NN	_	_	9	PMOD	_	_
13	.	_	.	_	_	3	P	_	_

1	Viren	_	NNP	_	_	2	NAME	_	_
2	Mehta	_	NNP	_	_	19	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	a	_	DT	_	_	5	NMOD	_	_
5	partner	_	NN	_	_	2	APPO	_	_
6	with	_	IN	_	_	5	NMOD	_	_
7	Mehta	_	NNP	_	_	6	PMOD	_	_
8	&	_	CC	_	_	7	COORD	_	_
9	Isaly	_	NNP	_	_	8	CONJ	_	_
10	,	_	,	_	_	7	P	_	_
11	a	_	DT	_	_	17	NMOD	_	_
12	New	_	NNP	_	_	13	AMOD	_	_
13	York-based	_	JJ	_	_	17	NMOD	_	_
14	pharmaceutical	_	JJ	_	_	17	NMOD	_	_
15	industry	_	NN	_	_	17	NMOD	_	_
16	research	_	NN	_	_	17	NMOD	_	_
17	firm	_	NN	_	_	7	APPO	_	_
18	,	_	,	_	_	7	P	_	_
19	said	_	VBD	_	_	0	ROOT	_	_
20	the	_	DT	_	_	21	NMOD	_	_
21	government	_	NN	_	_	23	NMOD	_	_
22	's	_	POS	_	_	21	SUFFIX	_	_
23	ruling	_	NN	_	_	24	SBJ	_	_
24	was	_	VBD	_	_	19	OBJ	_	_
25	n't	_	RB	_	_	24	ADV	_	_
26	unexpected	_	JJ	_	_	24	PRD	_	_
27	.	_	.	_	_	19	P	_	_

1	``	_	``	_	_	25	P	_	_
2	This	_	DT	_	_	3	SBJ	_	_
3	has	_	VBZ	_	_	25	OBJ	_	_
4	become	_	VBN	_	_	3	VC	_	_
5	a	_	DT	_	_	8	NMOD	_	_
6	very	_	RB	_	_	7	AMOD	_	_
7	politicized	_	JJ	_	_	8	NMOD	_	_
8	deal	_	NN	_	_	4	PRD	_	_
9	,	_	,	_	_	8	P	_	_
10	concerning	_	VBG	_	_	8	NMOD	_	_
11	Canada	_	NNP	_	_	20	NMOD	_	_
12	's	_	POS	_	_	11	SUFFIX	_	_
13	only	_	JJ	_	_	20	NMOD	_	_
14	large	_	JJ	_	_	20	NMOD	_	_
15	,	_	,	_	_	20	P	_	_
16	world-class	_	JJ	_	_	20	NMOD	_	_
17	bio-research	_	NN	_	_	20	NMOD	_	_
18	or	_	CC	_	_	17	COORD	_	_
19	pharmaceutical	_	JJ	_	_	18	CONJ	_	_
20	company	_	NN	_	_	10	PMOD	_	_
21	,	_	,	_	_	25	P	_	_
22	''	_	''	_	_	25	P	_	_
23	Mr.	_	NNP	_	_	24	TITLE	_	_
24	Mehta	_	NNP	_	_	25	SBJ	_	_
25	said	_	VBD	_	_	0	ROOT	_	_
26	.	_	.	_	_	25	P	_	_

1	Mr.	_	NNP	_	_	2	TITLE	_	_
2	Mehta	_	NNP	_	_	3	SBJ	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	move	_	NN	_	_	16	SBJ	_	_
6	that	_	WDT	_	_	7	SBJ	_	_
7	could	_	MD	_	_	5	NMOD	_	_
8	allow	_	VB	_	_	7	VC	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	transaction	_	NN	_	_	8	OBJ	_	_
11	to	_	TO	_	_	8	OPRD	_	_
12	go	_	VB	_	_	11	IM	_	_
13	ahead	_	RB	_	_	12	DIR	_	_
14	as	_	IN	_	_	12	MNR	_	_
15	planned	_	VBN	_	_	14	SUB	_	_
16	could	_	MD	_	_	3	OBJ	_	_
17	be	_	VB	_	_	16	VC	_	_
18	an	_	DT	_	_	20	NMOD	_	_
19	out-of-court	_	JJ	_	_	20	NMOD	_	_
20	settlement	_	NN	_	_	17	PRD	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	Connaught	_	NNP	_	_	24	NMOD	_	_
23	's	_	POS	_	_	22	SUFFIX	_	_
24	dispute	_	NN	_	_	21	PMOD	_	_
25	with	_	IN	_	_	24	NMOD	_	_
26	the	_	DT	_	_	27	NMOD	_	_
27	University	_	NNP	_	_	25	PMOD	_	_
28	of	_	IN	_	_	27	NMOD	_	_
29	Toronto	_	NNP	_	_	28	PMOD	_	_
30	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	University	_	NNP	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	seeking	_	VBG	_	_	3	VC	_	_
5	to	_	TO	_	_	4	OPRD	_	_
6	block	_	VB	_	_	5	IM	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	acquisition	_	NN	_	_	6	OBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	Connaught	_	NNP	_	_	9	PMOD	_	_
11	by	_	IN	_	_	8	NMOD	_	_
12	foreign	_	JJ	_	_	13	NMOD	_	_
13	interests	_	NNS	_	_	11	PMOD	_	_
14	,	_	,	_	_	4	P	_	_
15	citing	_	VBG	_	_	4	ADV	_	_
16	concerns	_	NNS	_	_	15	OBJ	_	_
17	about	_	IN	_	_	16	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	amount	_	NN	_	_	17	PMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	research	_	NN	_	_	20	PMOD	_	_
22	that	_	WDT	_	_	23	SBJ	_	_
23	would	_	MD	_	_	19	NMOD	_	_
24	be	_	VB	_	_	23	VC	_	_
25	done	_	VBN	_	_	24	VC	_	_
26	in	_	IN	_	_	25	LOC	_	_
27	Canada	_	NNP	_	_	26	PMOD	_	_
28	.	_	.	_	_	3	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	university	_	NN	_	_	3	SBJ	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	considering	_	VBG	_	_	3	VC	_	_
5	a	_	DT	_	_	7	NMOD	_	_
6	settlement	_	NN	_	_	7	NMOD	_	_
7	proposal	_	NN	_	_	4	OBJ	_	_
8	made	_	VBN	_	_	7	APPO	_	_
9	by	_	IN	_	_	8	LGS	_	_
10	Connaught	_	NNP	_	_	9	PMOD	_	_
11	.	_	.	_	_	3	P	_	_

1	While	_	IN	_	_	11	ADV	_	_
2	neither	_	DT	_	_	3	NMOD	_	_
3	side	_	NN	_	_	4	SBJ	_	_
4	will	_	MD	_	_	1	SUB	_	_
5	disclose	_	VB	_	_	4	VC	_	_
6	its	_	PRP$	_	_	7	NMOD	_	_
7	contents	_	NNS	_	_	5	OBJ	_	_
8	,	_	,	_	_	11	P	_	_
9	Mr.	_	NNP	_	_	10	TITLE	_	_
10	Mehta	_	NNP	_	_	11	SBJ	_	_
11	expects	_	VBZ	_	_	0	ROOT	_	_
12	it	_	PRP	_	_	11	OBJ	_	_
13	to	_	TO	_	_	11	OPRD	_	_
14	contain	_	VB	_	_	13	IM	_	_
15	more	_	RBR	_	_	16	AMOD	_	_
16	specific	_	JJ	_	_	17	NMOD	_	_
17	guarantees	_	NNS	_	_	14	OBJ	_	_
18	on	_	IN	_	_	17	NMOD	_	_
19	research	_	NN	_	_	18	PMOD	_	_
20	and	_	CC	_	_	19	COORD	_	_
21	development	_	NN	_	_	23	NMOD	_	_
22	spending	_	NN	_	_	23	NMOD	_	_
23	levels	_	NNS	_	_	20	CONJ	_	_
24	in	_	IN	_	_	19	LOC	_	_
25	Canada	_	NNP	_	_	24	PMOD	_	_
26	than	_	IN	_	_	17	NMOD	_	_
27	Merieux	_	NNP	_	_	28	SBJ	_	_
28	offered	_	VBD	_	_	26	SUB	_	_
29	to	_	TO	_	_	28	DTV	_	_
30	Investment	_	NNP	_	_	31	NAME	_	_
31	Canada	_	NNP	_	_	29	PMOD	_	_
32	.	_	.	_	_	11	P	_	_

1	Some	_	DT	_	_	2	NMOD	_	_
2	analysts	_	NNS	_	_	14	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	such	_	JJ	_	_	5	DEP	_	_
5	as	_	IN	_	_	2	NMOD	_	_
6	Murray	_	NNP	_	_	7	NAME	_	_
7	Grossner	_	NNP	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Toronto-based	_	JJ	_	_	11	NMOD	_	_
10	Richardson	_	NNP	_	_	11	NAME	_	_
11	Greenshields	_	NNP	_	_	8	PMOD	_	_
12	Inc.	_	NNP	_	_	11	POSTHON	_	_
13	,	_	,	_	_	2	P	_	_
14	believe	_	VBP	_	_	0	ROOT	_	_
15	the	_	DT	_	_	17	NMOD	_	_
16	government	_	NN	_	_	17	NMOD	_	_
17	ruling	_	NN	_	_	18	SBJ	_	_
18	leaves	_	VBZ	_	_	14	OBJ	_	_
19	the	_	DT	_	_	20	NMOD	_	_
20	door	_	NN	_	_	18	OBJ	_	_
21	open	_	JJ	_	_	18	OPRD	_	_
22	for	_	IN	_	_	21	AMOD	_	_
23	other	_	JJ	_	_	24	NMOD	_	_
24	bidders	_	NNS	_	_	22	PMOD	_	_
25	,	_	,	_	_	24	P	_	_
26	such	_	JJ	_	_	27	DEP	_	_
27	as	_	IN	_	_	24	NMOD	_	_
28	Switzerland	_	NNP	_	_	30	NMOD	_	_
29	's	_	POS	_	_	28	SUFFIX	_	_
30	Ciba-Geigy	_	NNP	_	_	27	PMOD	_	_
31	and	_	CC	_	_	30	COORD	_	_
32	Chiron	_	NNP	_	_	31	CONJ	_	_
33	Corp.	_	NNP	_	_	32	POSTHON	_	_
34	of	_	IN	_	_	32	NMOD	_	_
35	Emeryville	_	NNP	_	_	34	PMOD	_	_
36	,	_	,	_	_	35	P	_	_
37	Calif	_	NNP	_	_	35	APPO	_	_
38	.	_	.	_	_	14	P	_	_

1	Officials	_	NNS	_	_	17	SBJ	_	_
2	for	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	two	_	CD	_	_	5	NMOD	_	_
5	concerns	_	NNS	_	_	2	PMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	which	_	WDT	_	_	8	SBJ	_	_
8	are	_	VBP	_	_	5	NMOD	_	_
9	bidding	_	VBG	_	_	8	VC	_	_
10	C$	_	$	_	_	9	OBJ	_	_
11	30	_	CD	_	_	10	NMOD	_	_
12	a	_	DT	_	_	13	NMOD	_	_
13	share	_	NN	_	_	10	ADV	_	_
14	for	_	IN	_	_	9	ADV	_	_
15	Connaught	_	NNP	_	_	14	PMOD	_	_
16	,	_	,	_	_	17	P	_	_
17	could	_	MD	_	_	0	ROOT	_	_
18	n't	_	RB	_	_	17	ADV	_	_
19	be	_	VB	_	_	17	VC	_	_
20	reached	_	VBN	_	_	19	VC	_	_
21	for	_	IN	_	_	20	PRP	_	_
22	comment	_	NN	_	_	21	PMOD	_	_
23	.	_	.	_	_	17	P	_	_

1	French	_	JJ	_	_	2	AMOD	_	_
2	state-owned	_	JJ	_	_	3	NMOD	_	_
3	Rhone-Poulenc	_	NNP	_	_	5	SBJ	_	_
4	S.A.	_	NNP	_	_	3	POSTHON	_	_
5	holds	_	VBZ	_	_	0	ROOT	_	_
6	51	_	CD	_	_	7	NMOD	_	_
7	%	_	NN	_	_	5	OBJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	Merieux	_	NNP	_	_	8	PMOD	_	_
10	.	_	.	_	_	5	P	_	_

